Æterna Zentaris (AEZS) Partner Keryx Biopharma (KERX) Gets U.S. FDA Fast Track Designation for Perifosine
Tweet Send to a Friend
Æterna Zentaris Inc. (NASDAQ: AEZS) today announced that its partner, Keryx Biopharmaceuticals (NASDAQ: KERX), was granted Fast Track designation by ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
